Kombucha is a $3.5 billion industry. Ginger is backed by 50+ randomized controlled trials. Only one of these products has clinical evidence for its health claims.
The Evidence Gap
| Health Claim | Ginger Shot | Kombucha |
|---|---|---|
| Anti-inflammatory | 50+ RCTs | 0 human RCTs |
| Gut health | +25% gastric emptying (RCT) | Theoretical only |
| Weight loss | 14 RCTs, meta-analysis | 0 RCTs |
| Nausea relief | 6 RCTs (strong) | 0 RCTs |
| Immune boost | Multiple mechanisms | 0 RCTs |
| "Detox" | Glutathione +32% | No scientific definition |
Why Kombucha Falls Short
Kombucha is fermented sweet tea. It produces some organic acids and trace bacteria. But:
- No standardized probiotic content — strains and counts vary wildly
- Sugar: 4-12g/100ml — fermentation doesn't consume it all
- Zero completed human RCTs — all claims extrapolate from in-vitro
- Alcohol: 0.5-3% — often inaccurately labelled
Ginger's Measured Pharmacology
- NF-κB inhibition → anti-inflammatory (Grzanna et al., 2005)
- 5-HT3 antagonism → anti-nausea (Ernst & Pittler, 2000)
- Prokinetic → +25% gastric emptying (Hu et al., 2011)
- TRPV1 → +43 kcal/day thermogenesis (Mansour et al., 2012)
These are measured in RCTs with hundreds of participants.
The Turmeric + Pepper Amplifier
Adding curcumin + piperine creates synergistic NF-κB inhibition with 2000% enhanced bioavailability. Kombucha can't replicate this pharmacological triad.
The Product
INTI — organic ginger + turmeric + black pepper, 1.19g sugar per 100ml. Clinical evidence, not fermentation folklore.
When a product's marketing budget exceeds its clinical trial budget, you're not buying health. You're buying hope.
Top comments (0)